HOPX and cutaneous melanoma: In addition, in vitro experiments using human malignant cutaneous melanoma cells showed that HOPX inhibited proliferation, migration, and invasion of A375 cells, promoted apoptosis and S-phase arrest, and may enhance the sensitivity of clinical chemotherapeutic agents.